Stuart Arbuckle, who’s been with Vertex since 2012, plans to retire from his role in July. His departure comes as Vertex ...

Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the ...

The ASX200 opened higher this morning by 0.25%, following a rally on Wall Street driven by Nvidia and metals stocks.

Vertex Pharmaceuticals Inc. will soon lose a member of its leadership team that helped the company achieve major revenue ...

Vertex (VRTX) stock was trading largely flat post-market after the company released its Q4 earnings report and issued 2025 ...

The cystic fibrosis treatment leader exceeded revenue expectations, but missed slightly on earnings per share.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

This norovirus case marks the seventh gastrointestinal illness outbreak on cruises this year that reached the CDC's threshold ...

State law has tried to bring more transparency to issues at North Carolina group homes that house adults living with mental ...

Royalty Pharma Plc (RPRX) reported its Q4 2024 earnings today, revealing earnings per share (EPS) of $0.3531, falling short of the forecasted $0.9849. The company also reported revenue of $594 million ...

While Kenyatta's faction appears to be backing Fred Matiang'i's presidential bid, Gachagua's camp seems to be leaning towards ...

Keep up with the markets, earnings, and economy with high-quality news from 1,000s of journalists around the world.